Cited by 475Coronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsCerebrovascular and Carotid Artery Diseases

Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome

Open access
Nicholls, Stephen J., Hsu, Amy, Wolski, Kathy, Hu, Bo, Bayturan, Ozgur, Lavoie, Andrea, Uno, Kiyoko, Tuzcu, E. Murat +1 more·2010·Journal of the American College of Cardiology

Abstract

Objectives The aim of this study was to investigate the relationship between intravascular ultrasound (IVUS)-derived measures of atherosclerosis and cardiovascular outcomes.Background IVUS has been used in clinical trials to evaluate the effect of medical therapies on coronary atheroma progression.Methods Coronary plaque progression was evaluated in 4,137 patients in 6 clinical trials that used serial IVUS. The relationship between baseline and change in percent atheroma volume (PAV) and total atheroma volume with incident major adverse cardiovascular events (MACE) was investigated.Results PAV increased by 0.3% (p < 0.001), and 19.9% of subjects experienced MACE (0.9% death, 1.8% myocardial infarction, 18.9% coronary revascularization). Greater baseline PAVs were observed in patients who experienced myocardial infarctions (42.2 +/- 9.6% vs. 38.6 +/- 9.1%, p = 0.001), coronary revascularization (41.2 +/- 9.3% vs. 38.1 +/- 9.0%, p < 0.001), or MACE (41.3 +/- 9.2% vs. 38.0 +/- 9.0%, p < 0.001). Each standard deviation increase in PAV was associated with a 1.32-fold (95% confidence interval: 1.22 to 1.42; p < 0.001) greater likelihood of experiencing a MACE. During follow-up (21.1 +/- 3.7 months), greater increases in PAV, but not total atheroma volume, were observed in subjects who experienced MACE compared with those who did not (0.95 +/- 0.19% vs. 0.46 +/- 0.16%, p < 0.001). Each standard deviation increase in PAV was associated with a 1.20-fold (95% confidence interval: 1.10 to 1.31; p < 0.001) greater risk for MACE. Multivariate analysis revealed that factors associated with MACE included baseline PAV (p < 0.0001), change in PAV (p = 0.002), smoking (p = 0.0002) and hypertension (p = 0.01).Conclusions A direct relationship was observed between the burden of coronary atherosclerosis, its progression, and adverse cardiovascular events. The relationship between disease progression and outcomes largely reflected the need for coronary revascularization. These data support the use of atherosclerosis imaging with IVUS in the evaluation of novel antiatherosclerotic therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.02.026

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Combination therapy using a statin and a PCSK9 inhibitor prevents ASCVD incidence in patients with a history of myocardial infarction, nonhemorrhagic stroke, or peripheral arterial disease.

    “Combination therapy using statin and PCSK9 inhibitor prevents ASCVD incidence in patients with a history of myocardial infarction, nonhemorrhagic stroke, or PAD. (Evidence level 1+, recommendation level: B).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nicholls, S. J., Hsu, A., Wolski, K., Hu, B., Bayturan, O., Lavoie, A., Uno, K., Tuzcu, E. M., & Nissen, S. E.
Affiliations
Cleveland Clinic (US)
Corresponding author
Nicholls, Stephen J.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2010-05
Volume
55
Issue
21
Pages
2399-2407
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2054455620
Cited by
475
References
29
Citations by year
2026: 20 · 2025: 15 · 2024: 15 · 2023: 25 · 2022: 31 · 2021: 22 · 2020: 24 · 2019: 33 · 2018: 35 · 2017: 32 · 2016: 52 · 2015: 40 · 2014: 41 · 2013: 29 · 2012: 24
FWCI
30.17
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
Funders
  • Daiichi-Sankyo
  • Roche
  • Novo Nordisk
  • Takeda Pharmaceutical Company
  • Pfizer
  • AstraZeneca
  • Anthera
Topics
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords
intravascular ultrasound, coronary artery disease, atheroma volume, plaque burden, major adverse cardiovascular events, myocardial infarction, coronary revascularization, plaque progression, cardiovascular risk prediction, smoking, coronary artery stenosis, coronary thrombosis
MeSH terms
Aged, Cardiovascular Diseases, Coronary Artery Disease, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Myocardial Revascularization, Probability, Severity of Illness Index, Cohort Studies, Multivariate Analysis, Confidence Intervals, Logistic Models, Survival Analysis, Treatment Outcome, Ultrasonography, Interventional, Disease Progression, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review